Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Progress in Biochemical Pharmacology
|
January 1, 1972
Antilipaemic drugs and nephrotic hyperlipidaemia
K D Edwards
The Medical Journal of Australia
|
December 19, 1970
Intestinal absorption of oligopeptides
K D Edwards
The Medical Journal of Australia
|
October 9, 1976
Plasma renin substrate and blood pressure after protacaval anastomosis
K D Edwards
The Medical Journal of Australia
|
March 7, 1970
Hyperlipaemia in experimental nephrosis and its control by chlorophenoxyisobutyrate and betabenzalbutyrate
K D Edwards, R Paoletti
Nephron
|
January 1, 1976
Increased prevalence of coronary heart disease in analgesic nephropathy: relation to hypertension, hypertriglyceridemia and combined hyperlipidemia
G Kaladelfos, K D Edwards
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1975
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia
G J Schapel, K D Edwards
The Medical Journal of Australia
|
January 23, 1971
Analgesic nephropathy. Changes in various parameters of renal function following cessation of analgesic abuse
T W Steele, K D Edwards
Progress in Biochemical Pharmacology
|
January 1, 1974
Relation of hypertriglyceridaemia to kidney transplant dysfunction and rejection, and response to antilymphocyte globulin therapy
J A Charlesworth, K D Edwards
Lancet (London, England)
|
May 26, 1973
Is control of hyperlipidaemia important in kidney transplantation?
K D Edwards, J A Charlesworth
Clinical and Experimental Pharmacology & Physiology
|
November 1, 1976
A third dipeptide carrier system typified by l-prolyl-lhydroxyproline and independent of l-leucyl and beta-alanyl dipeptides in rat gut loops
V J Gupta, K D Edwards
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Progress in Biochemical Pharmacology
|
January 1, 1972
Antilipaemic drugs and nephrotic hyperlipidaemia
K D Edwards
The Medical Journal of Australia
|
December 19, 1970
Intestinal absorption of oligopeptides
K D Edwards
The Medical Journal of Australia
|
October 9, 1976
Plasma renin substrate and blood pressure after protacaval anastomosis
K D Edwards
The Medical Journal of Australia
|
March 7, 1970
Hyperlipaemia in experimental nephrosis and its control by chlorophenoxyisobutyrate and betabenzalbutyrate
K D Edwards, R Paoletti
Nephron
|
January 1, 1976
Increased prevalence of coronary heart disease in analgesic nephropathy: relation to hypertension, hypertriglyceridemia and combined hyperlipidemia
G Kaladelfos, K D Edwards
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1975
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia
G J Schapel, K D Edwards
The Medical Journal of Australia
|
January 23, 1971
Analgesic nephropathy. Changes in various parameters of renal function following cessation of analgesic abuse
T W Steele, K D Edwards
Progress in Biochemical Pharmacology
|
January 1, 1974
Relation of hypertriglyceridaemia to kidney transplant dysfunction and rejection, and response to antilymphocyte globulin therapy
J A Charlesworth, K D Edwards
Lancet (London, England)
|
May 26, 1973
Is control of hyperlipidaemia important in kidney transplantation?
K D Edwards, J A Charlesworth
Clinical and Experimental Pharmacology & Physiology
|
November 1, 1976
A third dipeptide carrier system typified by l-prolyl-lhydroxyproline and independent of l-leucyl and beta-alanyl dipeptides in rat gut loops
V J Gupta, K D Edwards
Page
of 5